INTERACTION OF BENZODIAZEPINES WITH NEUROLEPTICS AT CENTRAL DOPAMINE NEURONS

被引：109

作者：

KELLER, HH ^{[1
]}

SCHAFFNER, R ^{[1
]}

HAEFELY, W ^{[1
]}

机构：

[1] F HOFFMANN LA ROCHE & CO LTD,DIV PHARM RES,CH-4002 BASEL,SWITZERLAND

来源：

关键词：

D O I：

10.1007/BF00692778

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 7

页数：7

共 35 条

[1] ANAGNOSTE B, 1974, J PHARMACOL EXP THER, V191, P370
[2] INHIBITION OF TURNOVER OF BRAIN DOPAMINE AFTER TREATMENT WITH GAMMAAMINOBUTYRATE - 2-OXYGLUTARATE TRANSAMINASE INHIBITOR AMINOOXYACETIC ACID
ANDEN, NE
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 283 (04) : 419 - 424
[3] ANDEN NE, 1963, LIFE SCI, V2, P448
[4] ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360
[5] DRUG-INDUCED CHANGES OF DOPAMINE TURNOVER IN STRIATUM AND LIMBIC SYSTEM OF RAT
BARTHOLINI, G
KELLER, HH
PLETSCHER, A
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (06) : 439 - 442
[6] EFFECTS OF CLOZAPINE ON CEREBRAL CATECHOLAMINERGIC NEURON SYSTEMS
BARTHOLINI, G
HAEFELY, W
JALFRE, M
KELLER, HH
PLETSCHER, A
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 46 (04) : 736 - 740
[7] Bartholini G., 1973, BENZODIAZEPINES, P235
[8] BOISSIER JR, 1963, THERAPIE, V18, P1257
[9] BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[10] BUNNEY BS, 1975, PRE POSTSYNAPTIC REC, P89